Human research findings
- Component-level: GHK-Cu has documented topical human research; the other components are preclinical or use-based.
- The specific four-peptide blend has not been evaluated in dedicated human trials.
- Reported accelerated wound and tissue healing and reduced inflammation in models.
- Reported improved skin elasticity and recovery markers, with effects building over several weeks. Well tolerated; rare mild injection-site or “spicy” sensation from GHK-Cu.
